Topical diclofenac solution

Drugs

Volumn 69, Issue 18, 2009, Pages 2621-2632

  Moen, Marit D ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; PARACETAMOL; PENNSAID; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APPLICATION SITE REACTION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG METABOLISM; DRUG TOLERABILITY; DRY SKIN; DYSPEPSIA; EDEMA; EMBASE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KNEE OSTEOARTHRITIS; MEDLINE; NAUSEA; PARESTHESIA; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SINGLE BLIND PROCEDURE; SKIN PRURITUS;

ACTIVITIES OF DAILY LIVING; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS AS TOPIC; DICLOFENAC; DIMETHYL SULFOXIDE; DRUG ADMINISTRATION SCHEDULE; FREE RADICAL SCAVENGERS; HUMANS; ONTARIO; OSTEOARTHRITIS, KNEE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PAIN MEASUREMENT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN DISEASES; SOLUTIONS; TREATMENT OUTCOME;

EID: 71849098471     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11202850-000000000-00000     Document Type: Review

References (20)

1. Ozguney I. An alternative topical treatment of osteoarthritis of the knee with cutaneous diclofenac solution. Expert Opin Pharmacother 2008 Jul; 9 (10): 1805-1816
2. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recom-mendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008 Feb; 16 (2): 137-162
3. Brogden RN, Heel RC, Pakes GE, et al. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs 1980 Jul; 20 (1): 24-48.
4. Zacher J, Altman R, Bellamy N, et al. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin 2008 Apr; 24 (4): 925-950
5. Hooper L, Brown TJ, Elliott RA, et al. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ 2004 Oct 23; 329 (7472): 948.
6. Pennsaid® (1.5% w/w diclofenac sodium solution): Canadian prescribing information. Montreal (QC): Paladin Labs Inc., 2009 Apr 14.
7. Pennsaid®: UK summary of product characteristics. London: Dimethaid (UK) Limited, 2004 Feb 26.
8. Pennsaid® topical solution (diclofenac sodium topical solution). 5% w/w: US prescribing information. Hazelwood (MO): Mallinckrodt Brand Pharmaceuticals, Inc., 2009 Nov.
9. Todd PA, Sorkin EM. Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988 Mar; 35 (3): 244-285
10. Hui X, Hewitt PG, Poblete N, et al. In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers. Pharm Res 1998 Oct; 15 (10): 1589-1595 (Pubitemid 28465746)
11. Hewitt PG, Poblete N, Wester RC, et al. In vitro cutaneous disposition of a topical diclofenac lotion in human skin: effect of a multi-dose regimen. Pharm Res 1998 Jul; 15 (7): 988-992
12. Tanojo H, Wester RC, Shainhouse JZ, et al. Diclofenac metabolic profile following in vitro percutaneous absorption through viable human skin. Eur J Drug Metab Phar-macokinet 1999 Oct-Dec; 24 (4): 345-351
13. Baer PA, Thomas LM, Shainhouse Z. Treatment of osteo-arthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet Disord 2005 Aug 8; 6 (44).
14. Bookman AA, Williams KS, Shainhouse JZ. Effect of a to-pical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 2004 Aug 17; 171 (4): 333-338
15. Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med 2004 Oct 11; 164 (18): 2017-2023
16. Simon LS, Grierson LM, Naseer Z, et al. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain 2009 Jun; 143 (3): 238-245
17. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol 2004 Oct; 31 (10): 2002-2012
18. Pham T, Van Der Heijde D, Lassere M, et al. Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria. J Rheumatol 2003 Jul; 30 (7): 1648-1654
19. Towheed TE. Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials. J Rheumatol 2006 Mar; 33 (3): 567-573
20. Jones B, Jarvis P, Lewis JA, et al. Trials to assess equiva-lence: the importance of rigorous methods. BMJ 1996 Jul 6; 313 (7048): 36-9.